On the 29th, renowned American entrepreneur Elon Musk stated that his brain-computer interface companyNeuralink atThe first human transplant of a brain-computer interface device was performed on the 28th, and the recipient is currently recovering well. Musk posted on the social media platform X (formerly Twitter) that preliminary results show promising prospects for implantable brain-computer interface devices in detecting neuron-related potentials. According to Musk,NeuralinkThe company’s first brain-computer interface product, named “Telepathy,” enables users to control smartphones and computers, and thereby nearly all other devices, simply through thought after the device is implanted in the brain. Musk stated that the initial users of this product would be individuals who have lost limb function. “Imagine if, with an implanted brain-computer interface device, Stephen Hawking’s communication speed could potentially surpass that of a typist or an auctioneer. That is our goal.” NeuralinkThe company was founded in 2016 and focuses on the research and development of implantable brain-computer interface devices. The company stated that once implanted in the brain, these devices can read brain activity signals, with the aim of treating memory decline, cervical spinal cord injuries, and other neurological disorders. The goal is to help paralyzed individuals regain the ability to communicate with the outside world and even walk again. Last May, the company received approval from the U.S. Food and Drug Administration to launch human clinical trials for its brain implant device. In September of the same year, the company began recruiting volunteers for the clinical trials. Source: Xinhua News Agency
END
Intelligent Medical Device Laboratory
01
Laboratory Profile
The National Medical Products Administration Key Laboratory for Research and Evaluation of Intelligent Medical Devices, led by the China Academy of Information and Communications Technology, aims toConduct research and consultation, standard development, inspection and testing, experimental validation, and platform establishment, with a focus on the R&D and innovation of intelligent medical devices, enhancement of regulatory capabilities, and practical application of related achievements. Address bottlenecks and challenges in the industrial chain, and strive to produce a series of new regulatory tools, methods, standards, and systems for innovative medical devices.Strive to promote the translation and application of innovative achievements,Build internationally leading and domestically first-class intelligent medical device full lifecycle service capabilities, and construct a new ecosystem for the intelligent medical device industry.
02
Organizational Structure
The laboratory comprises five major research centers: the Remote Medical Device Research Center, the Artificial Intelligence Medical Device Research Center, the Network and Data Security Research Center, the Basic Technology Research Center, and the Regulatory Science Research Center.